Dr. Monica Wattana is a provider in the MD Anderson Emergency Center and an Assistant Professor in the Department of Emergency Medicine. She is board-certified in Emergency Medicine and joined MD Anderson in 2012. She is a member of American Board of Emergency Medicine since 2014. Degree-Granting Education 2008- University of California School of Medicine, Irvine, CA, USA, MD, Medicine Postgraduate Training 2012-2014 Clinical Fellowship, Emergency Medicine, Pain Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 2008-2012 Clinical Residency, Emergency Medicine, University of California at Los Angeles, Los Angeles, CA

Emergency Medicine

Professor Robert Bor is a chartered clinical, counselling and health psychologist registered with the Health and Care Professions Council. He is also a Fellow of the British Psychological Society and a UKCP registered family and couples therapist having specialised in systemic therapy at the Tavistock Clinic, London. Rob is an honorary civilian consultant to the Royal Air Force. He has published more than 30 books and 200 academic papers and chapters in books. He is a Liveryman of the Guild of Air Pilots and Air Navigators and also holds the Freedom of the City of London. Professor Bor is a Churchill Fellow. Qualifications DPhil CPsychol CSci FBPsS UKCP Reg FRAeS

Infectious diseases

Dr. Robert W. Buckingham joined PHHS after having previously been appointed as the Jack W. Thompson, M.D. Distinguished Visiting Professor at the University of Michigan-Flint in 2013-14. A Yale graduate, Dr. Buckingham was appointed inaugural Executive Director/Dean of the School of Public Health with the University of Saskatchewan, in 2009. He has authored more than 12 books and many scientific referred papers, with the most recent being a textbook entitled, “A Primer on International Health” published by Allyn & Bacon, and five books on hospice care, including, “Care of the Dying Child” published by the Continuum Publishing Company, which was translated in seven languages.

Dr. Buckingham, helped pioneer the development of the first Hospice in the U.S. and is considered one of the “Founding Fathers” of hospice in North America. He was the first Director of Research of hospice in Connecticut in 1974, and subsequently founded another 81 hospice programs worldwide, including a hospice for children afflicted with HIV/AIDS in Thailand. Dr. Buckingham has developed new collaborative research and scholarly exchanged programs with Mahidol University in Thailand, Hawassa University in Ethiopia, as well as the Nelson Mandela Institute of Science and Technology in Arusha, Tanzania and locally, with the Heart and Stroke Foundation of Saskatchewan.

evin Galalae is the world’s foremost independent authority on the globalization-depopulation axis around which the international system has revolved since the inception of the United Nations in 1945, and the first to expose and scientifically demonstrate the existence, methods and consequences of the Global Depopulation Policy. He is the founder and Director of the Center of Global Consciousness (CGC), which is dedicated to the eradication of all covert chemical, biological, psychosocial and economic methods of population control and to their replacement with overt population control legislation through a global replacement level fertility law.

Biological and bacteriological methods, Causes and Consequences of the Global Depopulation Policy and Chemical and Biological Depopulation.

Head of UNESCO Chair sexual health & Human rights, and Public health professor in Paris Diderot University

Sexual health, Human Rights, HIV, STIs, Brief Sexual Communication, globale approach in sexual education, training of sexuality educator

Giulio Tarro graduated from Medicine School, Naples University (1962). Research Associate, Division of Virology and Cancer Research, Children’s Hospital (1965-1968), Assistant Professor of Research Pediatrics, College Medicine (1968-1969), Cincinnati University, Ohio. Oncological Virology Professor, Naples University (1972-1985). Chief Division Virology (1973-2003), Head Department Diagnostic Laboratories, (2003-2006). D. Cotugno Hospital for Infectious Diseases, Naples; Emeritus, 2006 -. Since 2007 Chairman Committee of Biotechnologies and VirusSphere, World Academy Biomedical Technologies, UNESCO, Adjunct Professor Department Biology, Temple University, College of Science and Technology, Philadelphia, recipient of the Sbarro Health Research Organization lifetime achievement award (2010). President Foundation de Beaumont Bonelli for Cancer Research.

Infectious Diseases

Edgar M. Carvalho is Professor of Medicine of the Federal University of Bahia Medical School and Senior Investigator of the Oswaldo Cruz Foundation. He is a clinic immunologist with expertise in the pathogenesis, Immunology and therapy of tropical diseases mainly in leishmaniasis, helminthic infections and Human T cell lymphotropic virus type 1 (HTLV-1 infection). He has developed the facilities to follow a large amount of patients as well as carriers in the endemic areas of the Schistosoma mansoni and Leishmania braziliensis infection and in a HTLV-1 clinic at the University Hospital of Federal University of Bahia.

Imunopathogenesis, host and parasite interaction

Prof. Eliora Ron serves as Scientific Advisor of BioPetroClean. Prof. Ron served as Scientific Director and Member of Scientific Advisory Committee at MIGAL - Galilee Research Institute LTD. until November 7, 2016. Prof. Ron is a Professor of Microbiology at Tel Aviv University. She serves as the author of more than 150 publications and holds several patents. She serves as Chair of Manja and Morris Leigh for Biotechnology and Biophysics. She serves as President of the Federation of European Microbiological Societies and Federation of Israeli Societies of Experimental Biology. Prof. Ron holds a Ph.D. in Microbiology from Harvard University.

Regulation of gene expression, Bacterial virulence, Use of bacteria to combat pollution

Professor Timms is Professor of Microbiology at the University of Sunshine Coast in Queensland, Australia. He is a nationally and internationally renowned microbiologist with specific expertise in the area of Chlamydia. His laboratory is acknowledged as the leading Australian laboratory and one of the leading groups internationally working on all aspects of chlamydial infections. His research group of 12 staff and students is developing vaccines and new diagnostics for chlamydial diseases in humans and animals as well as an improved understanding of chlamydial genomics, cell biology and pathogenicity. The group is widely acknowledged for its major contributions to chlamydial infections in koalas and other wildlife, including the development of a vaccine for koalas. He has published over 250 papers, reviews and book chapters in peer-reviewed international scientific journals.

Chlamydial infections and diagnosis

Luis Ulloa is Associate Professor of Rutgers - New Jersey Medical School, USA. His study focuses on innate immune responses to septic and aseptic conditions and their regulation by the nervous system in experimental models of sepsis and hemorrhage/Resuscitation.

Molecular mechanisms of neuronal modulation of the immune system, Bioelectronic immunology,

João R. Mesquita (D.V.M., M.Sc.; Ph.D.) is a Professor at the Polytechnic Institute of Viseu, Veterinary Section, where he teaches topics within Infectious Diseases for more than 10 years. On the past decade he has focused on Virology, where he has published 44 papers in Scopus indexed Journals. He has won several scientific prizes from different societies and conferences, where he has presented numerous oral and poster presentations.

Animal and human virology and Zoonotic viruses

Dr. Nassiri is a former Associate Dean of Global Health at the Michigan State University (MSU). He also served as MSU director of Institute of International Health. He is currently Professor of Pharmacology and Toxicology, Professor of Family and Community Medicine, and, lecturer in Global Health, Infectious Diseases and Tropical Medicine. He currently works on international public health issues relating to chronic diseases and has expertise in global health. He has made contributions in various fields of medical sciences including clinical investigation and health education. On the basis of his extensive experience and expertise in chronic infectious diseases including HIV/AIDS, TB as well as antimicrobial resistance and human gut microbiome, he developed clinical research programs in Brazil, South Africa, Haiti, Dominican Republic and Mexico. He had served as editorial board member for the journal of HIV and AIDS Review. He is currently on editorial board member for AIDS Patient Care and STDs. Prof. Nassiri has delivered seminar presentations on Tropical Medicine, HIV/AIDS, TB, Global Health and public health interventions in numerous national and international conferences and workshops. He is internationally recognized for his work in the areas of building effective international partnerships particularly in global health, community health, clinical care capacity building, and technical assistance mechanism. He is the founder of Michigan State University Osteopathic and Primary Health Clinic in Merida, Yucatan, Mexico. He has developed academic and research partnership programs with Federal University of Para Institute of Tropical Medicine in Belem, Brazil.

His research interests are Clinical Pharmacology of HIV/AIDS & TB, human gut microbiome, antibiotic resistance, prevention and control of infectious diseases, neglected tropical diseases, community health, global health, socio-ethical determinants of health, and community-based public health interventions. In collaboration with his Brazilian colleagues, he conducts research in the eastern Brazilian Amazon population on incidence and prevalence of HIV, TB, Hepatitis C, HPV, and antimicrobial resistance.

Dr. Qingzhong Kong graduated with B.S. and M.S degrees in Biochemistry at Nanjing University, China, in 1987 and 1990, respectively. In 1996, he completed a Ph.D. in Molecular Virology at the University of Massachusetts. From 1996 to 2000, he was a Research Associate in Molecular Immunology at Yale University, after which he joined the Department of Pathology at Case Western Reserve University as an assistant professor. Dr. Kong is currently a tenured Associate Professor of Pathology at Case Western Reserve University, where he also holds secondary appointments at the Department of Neurology and the National Center for Regenerative Medicine.

His laboratory focuses on prion diseases, functions of cellular prion protein, and muscle stem cells, including four main research areas: (1) etiology of sporadic Creutzfeldt-Jacob disease (CJD) in humans; (2) public health risks of animal prions (Chronic Wasting Disease of elk and deer, atypical Bovine Spongiform Encephalopathy of cattle, and Transmissible Mink Encephalopathy) and animal modeling of various human prion diseases (especially CJD); (3) the roles of the normal cellular prion protein in the biology and pathology of skeletal muscles and brain; and (4) muscle stem cells. His lab has created dozens of transgenic mouse lines for the above research areas, some of which are inducible by doxycycline or conditional when used with Cre recombinase expressing mice.

Yiping Li, Ph.D., Professor of Molecular Virology, Institute of Human Virology, Zhongshan School of Medicine, Sun Yat-sen University (SYSU), Guangzhou, China. Dr. Yiping Li received Ph.D. degree in Biochemistry and Molecular Biology from China Agricultural University, Beijing, China. From 2003 to 2004 and 2006 to 2007, Dr. Li worked as a visiting scholar, project researcher, and postdoctoral researcher in the National Veterinary Institute, Technical University of Denmark (previous Royal Danish Veterinary Institute). In 2005, Dr. Li pursued hepatitis C virus (HCV) research in the Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Canada. To continue HCV research, in February 2008 Dr. Li joined the Copenhagen Hepatitis C Program (CO-HEP), Hvidovre Hospital and Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. After trainings as a postdoc and senior investigator, Dr. Li took a professor position in Zhongshan School of Medicine, SYSU in January 2014

Dr. Yiping Li’s research interests are in the infection and immunity of HCV. To HCV research, Dr. Li has made important contributions, which have included the discoveries on the host RNA insertion-mediated viral resistance to antiviral effect of miR-122 antagonism, the development of novel full-length infectious culture systems for HCV genotypes 1a, 2a and 2b, as well as chimeric culture systems for HCV genotypes 3a, 4a, 5a, and 6a. Dr. Li’s works have led to publications on well-known journals, such as PNAS, Gastroenterology, Hepatology, PLoS Pathogens, Virology. In addition, Dr. Li also worked on animal viruses and Campylobacter. Dr. Li’s research activities have produced 25 publications, 3 U.S. patent applications and 21 conference abstracts; these have included 12 first author publications (served also as corresponding author in 3 publications) and 5 oral presentations out of 13 first author abstracts in outstanding conferences.

María José Figueras is a researcher at the Department of Basic Medical Sciences of the URV, and a state ambassador for the American Society of Microbiology (ASM, American Society for Microbiology). The network of ambassadors of the ASM aims to promote knowledge of microbiology through state representatives throughout the world. Dr. Figueras now has the mission of strengthening the relationship between the ASM and the scientific community in Spain, as well as collaborating globally with the more than 70 ambassadors of the entity. The ASM is one of the oldest and largest scientific societies in the world. The entity currently has more than 40,000 members, almost half of whom reside outside the United States. Among its objectives is the improvement of health, the environment and economic well-being, through the development and communication of microbiological sciences. María José Figueras graduated (1979) and PhD (1986) in Biology from the University of Barcelona and specialized in electronic microscopy at the University of Groningen (Netherlands). He has developed his professional career in the Biology and Microbiology Unit of the Faculty of Medicine and Health Sciences of the Rovira i Virgili University, where he has been Professor of Microbiology since 2000. In 2012, he received URV recognition for quality of its research with an impact superior to the world average in the area of Microbiology.

Water related and waterborne infections, Taxonomy and epidemiology of the emerging pathogens Aeromonas and Arcobacter and Taxonomy and epidemiology of the Legionella.

He graduated from the National Autonomous University of Mexico (UNAM, 1985-1989), Assistant Professor of the Department of Veterinary Surgery at UNAM 1989-l993. He is diploma in Surgery and Orthopedics in small species. He is founding President of the Association of Veteran Doctors Specialists in Small Species of Celaya, External Advisor of IDEXX Laboratories, and world leader in diagnostic equipment since 2003. He is currently Director of cirugiaveterinaria.mx National and Latin American Speaker in the area of diagnosis and Surgery. He is author of video books of continuous training in veterinary surgery.

Prevalence of zoonotic diseases in animals.

Dr.R Harihara Prakash is the Principal and Professor at K M Patel Institute of Physiotherapy,Karamsad. He has 18 years of professional experience in clinical as well as academics. He is a Doctorate in Physical Therapy from National University of Medical Sciences, Spain. He was awarded with Rashtriya Vidhya Saraswathi Puraskar Award for his excellent contribution in academics. He was former Dean, Faculty of Physiotherapy, Baba Farid University of Health Sciences, Punjab. He is in the Editorial Board and peer reviewer for some international journals. He is also in the panel of NAAC. He has obtained various skills by certification in the field of neurology, osteopathy, manual therapy from various countries. He has published and presented research papers in various national and international conferences. He is an eminent speaker and an academician.

Physiotherapy in preventive and promotive health.

Dr. Pankaja Raghav is Post graduate (MD) from Aurangabad University and joined D Y Patil Medical College, Pune (1998-2010), she was appointed as Head of the Community medicine Department at ACS Medical College, Chennai (2010 -2012) and now she is working as Professor & Head of the Department of Community medicine & Family medicine at AIIMS, Jodhpur since 2012. She also did postgraduate diploma in hospital & health management (PGDHHM) in 2006 & FAIMER Fellowship in 2013.She has 17 years of post MD teaching & research experience. She has carried out a number of research studies in the fields of nutrition, communicable diseases, non-communicable chronic diseases, child behavior, adolescents, accidents, substance abuse & medical education. She has published over 30 research articles in national and international journals of repute and has been on editorial board for the journals.Awarded the “Most Popular and the Best Teacher” of Padm. D. Y. Patil Medical University in 2008 and University Gold Medal for PGDHHM , IGNOU ,New Delhi; award was given by Vice President of India. She is the life member of many professional bodies to name a few Founder Member and Vice President of Indian Public Health Association, Rajasthan Chapter Member of ‘Consultation Group’ of experts and stakeholders to understand epidemiology of re-emerging H1N1 and other communicable diseases. She is a Member of National Academy of Sciences (India).

Non-communicable diseases, Nutrition and Medical education.

Dr Afzali is a Senior Research Fellow (health economics) with expertise in the economic evaluation of health technologies with a focus on the application of decision analytic modelling techniques. He is also a member of the Evaluation Sub-Committee (ESC) of the Medical Services Advisory Committee (MSAC) whose role is to advise the Australian government on evidence relating to the safety, effectiveness and cost-effectiveness of new medical technologies and procedures. Dr Afzali is involved in a number of research projects aiming to improve the decision making process around the funding of health technologies. He also co-leads the Adelaide Health Economics Research Group at the University of Adelaide.

Economic evaluation of health technologies, Decision analytic modelling for health economic evaluation, Improving public funding decision processes

Dr. Reza Nassiri is Associate Dean of Global Health; Director of Institute of International Health; Professor of Clinical Pharmacology, Professor of Family and Community Medicine, and lecturer in Global Health, Infectious Diseases and Tropical Medicine at Michigan State University College of Osteopathic Medicine. His research interests focuses on Clinical Pharmacology of HIV/AIDS & TB, prevention and control of infectious diseases, neglected tropical diseases, community health, global health, and socio-ethical determinants of health. Prof. Nassiri works on international public health issues and has expertise in global health education, research, policy and governance. He has made contributions in various fields of medical sciences including clinical investigation and health education. One the basis of his extensive experience and expertise in HIV/AIDS and TB, he developed Clinical Research Programs in Brazil, South Africa, Haiti, Dominican Republic and Mexico. The core foci of such programs are socio-cultural, bio-ethical determinant of HIV/AIDS and TB prevention, control, and intervention.

International health initiatives, Health in developing nations, HIV/AIDS research

Giulio Tarro graduated from Medicine School, Naples University (1962). Research Associate, Division of Virology and Cancer Research, Children’s Hospital (1965-1968), Assistant Professor of Research Pediatrics, College Medicine (1968-1969), Cincinnati University, Ohio. Oncological Virology Professor, Naples University (1972-1985). Chief Division Virology (1973-2003), Head Department Diagnostic Laboratories, (2003-2006). D. Cotugno Hospital for Infectious Diseases, Naples; Emeritus, 2006 -. Since 2007 Chairman Committee of Biotechnologies and VirusSphere, World Academy Biomedical Technologies, UNESCO, Adjunct Professor Department Biology, Temple University, College of Science and Technology, Philadelphia, recipient of the Sbarro Health Research Organization lifetime achievement award (2010). His researches have been concerned with the characterization of specific virus-induced tumour antigens, which were the "finger-prints" left behind in human cancer. Achievements include patents in field; discovery of Respiratory Syncytial Virus in infant deaths in Naples and of tumor liberated protein as a tumor associated antigen, 55 kilodalton protein overexpressed in lung tumors and other epithelial adenocarcinomas.Hh4is basic researches have been concerned with antigens induced early during the replication cycle of human herpesviruses. Another study has involved the identification, isolation and characterization of specific virus-induced tumour antigens, which were the “finger-prints” left behind in human cancer. Achievements include patents in field; discovery of Respiratory Syncytial Virus in infant deaths in Naples and of tumor liberated protein as a tumor associated antigen, 55 kilodalton protein overexpressed in lung tumors and other epithelial adenocarcinomas.

His basic researches have been concerned with antigens induced early during the replication cycle of human herpesviruses. Another study has involved the identification, isolation and characterization of specific virus-induced tumour antigens, which were the “finger-prints” left behind in human cancer. Achievements include patents in field; discovery of Respiratory Syncytial Virus in infant deaths in Naples and of tumor liberated protein as a tumor associated antigen, 55 kilodalton protein overexpressed in lung tumors and other epithelial adenocarcinomas.

Andrzej Tadeusz Zielinski was born in 1940 at Radom, Poland. In 1965, he completed his diploma of physician at Akademia Medyczna (Medical School), Warsaw, in 1968, he served as a doctor of medical sciences at Academia Medyczna (Medical School), Warsaw. Later in 1977, he was at Medical Examination of Educational Commission for Foreign Medical Graduates (ECFMG No: 280-257-7). While in 1982 he received his first degree specialty in internal diseases and achieved his second degree specialty in internal diseases in the year 1986, later in 1999 he was certified for Master of Science in Epidemiology at State University of New York, School of Public Health, and Albany, NY, U.S.A. Dr. Andrzej Tadeusz Zielinski started his employment in 1965-1979 in Department of Physiology at Akademia Medyczna (Medical School), Warsaw. Later in 1973-1974 and 1979-1980 he worked as an assistant professor (visiting) in Department of Pharmacology at Michigan State University, and East Lansing, Michigan, USA. From 1981-1986, he served as an Attending physician and director of outpatient clinic in Pruszków, Poland. In between the years 1986-990 he was an attending physician at Clinic of Internal Medicine in First Clinical Hospital at Medical Academy in Warsaw. He continued his passion as attending physician at Spellman Center for HIV Related Diseases in between 1991-1993 at St. Clare’s Hospital, New York, N.Y., U.S.A. He was later appointed as a clinical v-director, AIDS Diagnosis and Therapy Center, Warsaw in the years 1993 and 1996. Since 1999 he continued his Employment in National Institute of Public Health, National Institute of Hygiene, Warsaw in Poland. Later from 2003-2010 he worked as a Professor and Head of the Department of Epidemiology and since 2010 he is known to be the Professor Emeritus in the Department of Epidemiology. He also worked as National Consultant of Epidemiology from 2002- 2013, He is also an Editor-in-Chief of “Przegląd Epidemiologiczny” (Polish Epidemiological Review) from since 2000. He is yet now from 2005-2013 is also known to be the Member of Advisory Forum of ECDC. Dr. Andrzej Tadeusz Zielinski Memberships of scientific societies include: Warsaw Learned Society, Polish Epidemiological Association, and Polish Scientific Society of AIDS. Polish Society of Epidemiologists and Infectiologists.

Pharmacology, Epidemiology, AIDS Diagnosis and Therapy etc.

Shahryar Eghtesadi received Bachelor degree in Nutrition Science and Food Chemistry 1975, from Shahid Beheshti University of Medical Sciences, Tehran; MSPH degree in Nutrition, 1977, from Tehran University of Medical Sciences, Tehran and PhD from University of California at Davis(UCD), USA, in Nutrition (1985). He served as Visiting Scientist in USDA Human Nutrition Research Center on Aging (HNRCA), Boston, USA (1994-1995); full professor of Tabriz, Iran and Tehran Universities of Medical Sciences and currently serves as Professor of Azad University, Science & Research Branch. He was the chairs of Departments of Nutrition and Biochemistry, Biochemistry & Clinical Nutrition, Public Health Nutrition and Nutrition in aforementioned Universities. Also Served as Associate Dean and Dean of School of Public Health & Nutrition and School of Public Health of Tabriz and Iran Universities of Medical Sciences respectively. He was selected as distinguished professor and Scientist. For long and extended period of time, experienced teaching various courses in nutrition in undergraduate, graduate and postgraduate and international Bureau programs and directed many projects and dissertation of MS and PhD programs and Published numerous peer reviewed articles in journals and also edited several books and finally served as Principal Investigator of World Bank Project for Capacity Building in Nutrition in Iran.

Nutrition Science, Food Chemistry, Public Health

Ulku Anik was born in Nicosia, Cyprus in 1973. She has received her Ph.D. degree in Analytical Chemistry in Ege University, Bornova, İzmir-Turkey in 2003. She is currently a full professor at the Department of Chemistry, Mugla Sıtkı Kocman University, Mugla, Turkey. Her research interests are nanomaterial based electrochemical/bioelectrochemical systems,electrochemical sensors and biosensors, centri-voltammetry/biocentri-voltammetry, biofuel cells and electroanalytical chemistry. She has recently focused on developing electronano diagnostic platforms for detection of important diseases like influenza and cancer. Up to now, she has published more than 60 papers and directed many projects. She has also visited many labs all around the world and have collaborations with many important research groups.

Nanomaterial based electrochemical/bioelectrochemical systems,electrochemical sensors and biosensors, centri-voltammetry/biocentri-voltammetry, biofuel cells and development of electronano diagnostic platforms.

Jaroslav Turánek has completed his PhD at the age of 27 years from Masaryk University Brno. He is the head of Department of Pharmacology and Immunotherapy, Veterinary Research Institute, Brno. He has published more than 75 papers on vaccines, drug targeting, anticancer and antimicrobial drugs in reputed journals. He is teaching immunology, biotechnology and immunochemistry at Masaryk University Brno and Technical univeersity Brno. He is president of Czech Society for Gene and Cell Therapy and Principal Investigator of vast multidisciplinar project OPVVV FIT “Pharmacology, Immunotherapy, nanoToxicology” focused on applicaton of complex nanotechnology and biotechnology approach for development of new modern vaccines and targeted drug delivery systems

His research interest are Pharmacology and immunotherapy, drug delivery, nanotechnology, recombinant vaccines and molecular adjuvants.

Laushkina Zhanna works as a senior researcher and as a physician in the Novosibirsk Tuberculosis Research Institute since 1994. She got her PhD degree in 1999 and her Doctor of Medicine degree in 2016. Currently she works as a leading researcher and her main scientific interest is the issues of differential diagnosis of pulmonary tuberculosis and other lung diseases.

Differential diagnosis of pulmonary tuberculosis and other lung diseases

Tiziana Greggi Specialized works in Orthopedics and Traumatology, at the University of Bologna, Specialized in Biomedical Technologies, at the University of Bologna and she is the Head of Simple Departmental Structure: Spinal deformity surgery. She has worked in the Division of Spine Surgery of the Rizzoli Institute, first as an assistant and then as a senior manager. From 2000 to 2008 he received temporary positions as Director of a complex structure. From the end of this position to date has been responsible for the Organizational Module "the spinal deformities in pediatric age and associated with rare diseases" in the same Division. He is also responsible for a specialized clinic dedicated to the study and treatment of severe spinal deformities associated with rare diseases at the Rizzoli Orthopedic Institute. He is currently Head of the Departmental Simple Structure: Spinal deformity surgery

Spinal deformit, Spinal Surgery

Dr. Bhat has over 18 years’ experience in drug discovery and development and prior to founding Reviva, he held research positions at XenoPort, ARYx Therapeutics and Higuchi Biosciences Center in the United States. Dr. Bhat has received a global post-doctoral training at the University of Kansas, USA, the Georg-August-Universität, Göttingen, Germany and the Université du Maine, France. In 1995, he was selected for the Alexander von Humboldt fellowship, an internationally recognized award for young scientists to pursue advanced research in Germany. Dr. Bhat received his Ph.D. in synthetic organic chemistry from the Central University (NEHU), India and has authored over 15 research papers published in peer-reviewed scientific journals. Dr. Bhat is an inventor on more than 100 filed patents and over 35 granted patents

Drug Discovery

The Department of Department of Infectious Diseases / Tropical Medicine, Nephrology and Rheumatology at St. Georg Hospital in Leipzig is about regional focus clinic and competence center for infectious diseases for the state of Saxony

Infectious Diseases & Resarch

Stef Stienstra works internationally for several medical and biotech companies as scientific advisory board member and is also an active reserve-officer of the Royal Dutch Navy in his rank as Commander (OF4). For the Dutch Armed Forces he is CBRNe specialist with focus on (micro)biological and chemical threats and medical- and environmental functional specialist within the 1st CMI (Civil Military Interaction) Battalion of the Dutch Armed Forces. For Expertise France he is now managing an EU CBRN CoE public health project in West Africa. In his civilian position he is at this moment developing with MT-Derm in Berlin (Germany) a novel interdermal vaccination technology as well as a new therapy for cutaneous leishmaniasis for which he has won a Canadian ‘Grand Challenge’ grant. With Hemanua in Dublin (Ireland) he has developed an innovative blood separation unit, which is also suitable to produce convalescent plasma for Ebola Virus Disese therapy. He has finished both his studies in Medicine and in Biochemistry in The Netherlands with a doctorate and has extensive practical experience in cell biology, immuno-haematology, infectous diseaases, biodefense and transfusion medicine. His natural business acumen and negotiation competence helps to initiate new successful businesses, often generated from unexpected combinations of technologies.

Infectious Diseases

An expert in international health initiatives, health in developing nations, HIV/AIDS research

Infection Diseases, Neglected Diseases

An expert in international health initiatives, health in developing nations, HIV/AIDS research

Infectious Diseases, Infection Prevention, and HIV/AIDS Research

The Department of Department of Infectious Diseases / Tropical Medicine, Nephrology and Rheumatology at St. Georg Hospital in Leipzig is about regional focus clinic and competence center for infectious diseases for the state of Saxony

Infectious Diseases

Regional Director for Infection Prevention and Control, Taif – Saudi Arabia, and also worked in Philosophy of Medical Science, Clinical Microbiology in Sweden. He also Became Infection Prevention and Control Director, King Abdul Aziz Specialist Hospital – Taif, Saudi Arabia, and published many International articles on prevention of central line –associated bloodstream infection, WHO- Hand Hygiene implementation program, prevention sharp injuries in healthcare settings and molecular genotyping for epidemiological purposes and also participated in the Poster and oral presentations in many international conferences

Infection Prevention and Control

Ishwar Gilada: A medical doctor, specialized in Skin & STDs with special training in HIV management, Managing Director and Consultant in HIV/AIDS at Unison Medicare& Research Centre-India’s first private sector comprehensive HIV Care clinic; President of AIDS Society of India (a professional organization of physicians in HIV care); Secretary General of Peoples Health Org. (India). He was Secretary General of ASI from 2005-2011 and the Jt. Sec. of National AIDS Committee, Govt of India (1995-97). He was the first to raise alarm against AIDS in 1985, is known for bringing India on AIDS control map, had started India’s first AIDS Clinic-1986 and has expertise in HIV care in resource-poor settings. He had trained several doctors, nurses and social workers; he was Editor-Publisher of AIDS ASIA from 1993 to 2008. He initiated, managed, supervised, evaluated over 40 HIV/AIDS projects in India, addressed over 3700 public meetings and training programs in India and abroad, has 235 scientific papers at conferences, written chapters in books on AIDS/STDs. He was consultant for American Foundation for AIDS Research (AmFAR), World Vision, USAID; has more than 65 awards to his credit including the "Outstanding Young Person of the World" –Glasgow in 1995 and Annemarie Madison Award-Germany in 1999 in Munich, Germany where he was termed as ‘the Indian Machinegun against AIDS’.

Specialized in Skin & STDs with special training in HIV management

Dr. Guirakhoo joined GeoVax as Senior Vice President R&D in October 2015. Dr. Guirakhoo was named one of the ‘50 Most Influential People in Vaccines’ in Vaccine Nation’s 2014 list. His previous assignment was Chief Technology Officer at Vaxess Technologies, a Cambridge, MA, based biotechnology company researching thermostabilization of vaccines and biologics using silk fibroin protein. Prior to this, he served as Chief Scientific Officer at Hookipa Biotech in Vienna, Austria, developing vaccines against Cytomegalovirus and cancers based on a novel replication deficient viral vector platform. Prior to that, Dr. Guirakhoo held the position of Executive Director of External R&D at Sanofi Pasteur from 2007-20012. Before joining Sanofi Pasteur in 2007, Dr. Guirakhoo was Head of Virology Research at Acambis for 15 years. During this time, he co-invented the ChimeriVax TM -technology platform in association with St. Louis University. This platform utilizes the YF 17D vaccine virus as a vector to develop chimeric live viruses. The ChimeriVaxTM vector platform was successfully used in the development of innovative vaccines such as: a) a single dose vaccine against Japanese encephalitis (IMOJEV™), marketed in Asian countries by Sanofi, b) a single dose veterinary vaccine for the prevention of West Nile encephalitis (PREVNILE™), marketed by Merck Animal Health, and c) DENGVAXIA®, the world’s first dengue vaccine approved in Mexico and Brazil in December 2015 and marketed by Sanofi. This tetravalent vaccine represents a historic milestone for half of the world population who lives at risk of dengue. Dr. Guirakhoo has over 30 years of experience in developing vaccines against infectious diseases. Dr. Guirakhoo holds a BSc in Biology, a MSc in genetics, and a PhD in Virology from the Medical University of Vienna, Austria, and was awarded a National Research Council post-doctoral fellowship at the National Center for Disease Control and Prevention in Fort Collins, CO, from 1990-1992.

Catherine Mullié obtained a PhD in Microbiology and a PharmD at the University of Lille, France, in 1999. After a post-doc year at the Faculté de Medicine in Amiens (Laboratoire d’Immunologie, INSERM-EMI 0351), she was appointed as assistant professor at the Faculté de Pharmacie in Amiens in 2000 and joined the LG-2A (Laboratoire de Glycochimie des Antimicrobiens et des Agroressources, UMR 7378 CNRS) in 2008. She has been a member of the French Society for Microbiology since 2000. Her research is focused on the development of new antimicrobial and antimalarial drugs, with a special interest in efflux-mediated antibiotic resistance in Pseudomonas aeruginosa and Acinetobacter baumannii. She currently heads the French part of a bilateral project funded by France and Algeria (Partenariat Hubert Curien Tassili) on this topic.

development of new antimicrobial and antimalarial drugs, with a special interest in efflux-mediated antibiotic resistance in Pseudomonas aeruginosa and Acinetobacter baumannii

Professor Dr. Andy I.M. Hoepelman (26-03-1955) is Head of the Department of Infectious Diseases in the University Medical Center Utrecht in the Netherlands. Until 2016 he was also the head of the Department of Internal medicine. Since August 1st 1998, he is Professor in Medicine. Dr. Hoepelman received his medical training from the University of Utrecht, receiving his Doctorate in 1978 and his MD degree in 1980. He completed two internships at the University in 1980 and 1985 to earn his board certification as a specialist in Internal Medicine. He received his PhD in 1989. In 1991/1992 he worked at the Rockefeller University, New York (Laboratory Prof. E. Tuomanen) and at the Memorial-Sloan Kettering (Department of Infectious Diseases, Prof.dr. D. Armstrong). In 1993, he was board certified as a specialist in Infectious Diseases. He also heads the training programme in Infectious Disease for internal medicine specialists at the University Hospital Utrecht. He is author/co-author of more than 400 published articles and is a member of several professional associations. His research interests are pathogenesis and treatment of HIV and viral hepatitis. He won a bronze medal in waterpolo at the Montreal Olympics

pathogenesis, treatment of HIV and viral hepatitis

Huseyin Kayadibi was born and raised in Istanbul, Turkey. He received a Degree in Medicine from the GATA School of Medicine (Turkey) in 2000. He is an Associate Professor in Medical Biochemistry at Hitit University School of Medicine, where he is the head of Medical Biochemistry. He worked at Pasarow Mass Spectrometry Laboratory, University of California Los Angeles in 2012 as a visiting scholar. He has been a co-investigator on NIH and other international projects about metabolomic, proteomic and lipidomic analysis. He is the member of EFLM Working Group Test Evaluation and IFCC Working Group Cerebrospinal Fluid Proteins. He has published more than 70 papers in peer reviewed journals. His research interests are non-invasive assessment of liver fibrosis, separation techniques and mass spectrometry.

non-invasive assessment of liver fibrosis, separation techniques and mass spectrometry.

Refat Sadeq, Prof. and Head of Medical Microbiology and Immunology Department, Faculty of Medicine, Port said University, Egypt. He has been on microbiology field over 40 years. He has started and graduated in Zagazig Faculty of Medicine for M.Sc. and Ph.D. Then started to research articles reaching more than 80 articles, many of which have been published in international scientific journals, and he has reviewed over 150 articles on different journal sites. He is a Featured Author, for books in Medical Microbiology and Immunology for both medical students and nurses. Work from 2008-2011 as Head of Microbiology Department, Faculty of Medicine- Zagazig University. Also work as member of Egyptian scientific committee for graduation of Professor and assistant Professor in Microbiology in Egypt and some Arabic countries. He signed as Board editor of EC Microbiology Journal and Journal of Human Virology and Retrovirology. Since Oct 2014 he pointed as a Head of Microbiology and Immunology department, Faculty of Medicine, Port said University. He is very goal-oriented, assisted in building many units in his department but the favorite one was that of Virology and Molecular biology. He loves how to help junior doctors in his department to solve their scientific problems. His advice to new contributors is to take your time to get to know all the tools and to invest your energy and be sure that success will happened.

Virology and Molecular biology.

Professor Janak Kishore is Chief of Serology and Molecular Virology in the department of Microbiology, Sanjay Gandhi Post-graduate Institute of Medical Sciences, India. He was Associate Editor Indian Journal of Virology, member National Academy Medical Sciences, American societies and Fellow of JICA, Japan. His passion is on healing and minimising human sufferings; on unveiling emerging viral infections and finding aetiologies in viral epidemics and in investigating undiagnosed/missed clinical infections so that appropriate treatment is given and life is saved. Dr. Kishore taught for over 30 yrs with pioneer work on parvovirus B19, developed in-house molecular techniques and published three novel clinical associations besides finding novel oncolytic property of B19. He also worked on cytomegalovirus, enteroviral haemorrhagic conjunctivitis, rubella. Dr Kishore published over 50 papers, served as reviewer for reputed journals, organized conferences, Chaired sessions and frequently invited to speak at international conferences.

Emerging viral infections,Viral epidemics and Clinical Infectious Diseases.

Dr Ashok Kapse is consulting Pediatrician practicing in the city of Surat in the Gujrat state of India, besides owning a private pediatric hospital he is also head of the pediatric department at a prestigious Mahavir super specialty hospital. He has special interest and skill in infectious diseases. Working along with CDC Atlanta he evolved simple clinical approach for diagnosis and management of Dengue illnesses particularly in resource limited situations. Recipient of many oration awards he is a popular and sought after speaker, he has delivered hundreds of lectures on Dengue, Malaria, Typhoid and antibiotic uses across the India. He has published more than 10 articles in reputed national & international journals also has contributed chapters in prestigious books.

Dengue, Malaria, Typhoid and Antibiotics

Professor Dr. Reza Nejat (1963) is Chief of Khatam-ol-Anbia Hospital, Mashhad University of Medical Sciences, 1992-1994, Taibad City, Khorasan Province, Iran. Emergency Dept of Tehranpars General Hospital 1994-2009. Emergency Dept of Iranmehr General Hospital 1997-2000. Chief of Imam Khomeini Firuzkuh Hospital, Shahid Beheshti University of Medical Sciences, 2006-2007, Firuzkuh, Tehran Province, Iran. Directing Manager of Biotourism, Consultant to Deputy of Therapeutics, Shahid Beheshti University of Medical Sciences, 2007 to March, 2008. Member of managerial board of the committee of Health Tourism, Consultant to The Chancellor of Shahid Beheshti University of Medical Sciences in Health Tourism, March 2008-September 2008. Staff of Open Heart Surgery ICU of Day General Hospital, Tehran, Iran, June 2008-September 2009. Staff of ICU of Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran, August 2008-March 2011. Assistant Professor, Anesthesiology Dept. at Shahid Beheshti University of Medical Sciences, Tehran, Iran, March 2011 onward. Assistant Professor, Anesthesiology Dept., ICU at Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran, March 2011-April 2011. Assistant Professor, Anesthesiology Dept. at 15th Khordad Hospital, OR of plastic and reconstruction surgery, Shahid Beheshti University of Medical Sciences, Tehran, Iran, April 2011-April 2012. Assistant Professor, Anesthesiology Dept. at Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran, April 2012-January 2013. Critical Care fellowship programme at Sina Hospital, Tehran University of Medical Sciences, January 2013-July 2014. Assistant Professor, Fellowship of Critical Care Medicine (FCCM), ICU, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, July 2014-May 2015. Chief of CCM Dept., Bazarganan Hospital, Feb 2016- till now

Echocardiography, acute heart failure, stress response, sepsis and IVIG.